We understand that people with cancer are worried about coronavirus. Here is the latest guidance. We will update it regularly.

My Macmillan

Publications directory

Need to talk? Call us free*
0800 808 00 00 Monday to Friday, 9am-8pm

The web Directory of Information Materials for People Affected by Cancer is regularly updated and currently has details of over 1,900 booklets, leaflets, books and audiovisual materials for people affected by cancer. Most have been published in the last five years but we have included some older ones that are still useful.

Results: 1214

Cover image of 'Carfilzomib (Kyprolis®)'

Carfilzomib (Kyprolis®) (January 2019)

Myeloma UK

This treatment guide has information about carfilzomib, a proteasome inhibitor used in the treatment of myeloma. It describes how carfilzomib works, how it is given and the possible side effects.

Cover image of 'Prednisolone'

Prednisolone (January 2019)

Myeloma UK

Prednisolone is a steroid drug used in the treatment of myeloma. It belongs to a class of steroids called glucocorticoids. This factsheet describes what it is, how it works, how it is given, and the possible side-effects.

Cover image of 'Pomalidomide (Imnovid®)'

Pomalidomide (Imnovid®) (January 2019)

Myeloma UK

Pomalidomide, also known as Imnovid®, is an immunomodulatory drug used in the treatment of myeloma. This treatment guide describes how it works, how it is given and the possible side effects.

Cover image of 'Cyclophosphamide'

Cyclophosphamide (January 2019)

Myeloma UK

Cyclophosphamide is a chemotherapy drug used in the treatment of myeloma. It belongs to a class of chemotherapy drugs called alkylating agents. This factsheet describes what it is, how it works, how it is given, and possible side-effects.

Cover image of 'Venetoclax (Venclyxto®)'

Venetoclax (Venclyxto®) (August 2019)

Myeloma UK

This factsheet has information on venetoclax, a drug being investigated for the treatment of patients with the t(11;14) type of myeloma. It explains what venetoclax treatment is, how it works, and the current evidence to support its use in the treatment of myeloma. It also describes the known possible side-effects, and the availability of venetoclax in the UK.

Cover image of 'Panobinostat (Farydak®)'

Panobinostat (Farydak®) (January 2019)

Myeloma UK

This Treatment Guide contains information about panobinostat, a drug used in the treatment of myeloma. It describes what it is, how it works, how it is given, and the possible side-effects.

Cover image of 'Chemotherapy'

Chemotherapy (November 2019)

Orchid – Fighting Male Cancer

This leaflet describes how chemotherapy may be used to treat localised and non-localised testicular cancer, and the possible side-effects..

Cover image of 'Idelalisib'

Idelalisib (October 2019)

Lymphoma Action

Idelalisib is a targeted drug used in the treatment of certain types of lymphoma. This factsheet explains what it is, who can have it, how it is given, the benefits and possible side effects.

Cover image of 'Selinexor'

Selinexor (July 2019)

Myeloma UK

Selinexor is the first in a new family of drugs known as Selective Inhibitor of Nuclear Export (SINE™) compounds. This factsheet explains what it is, how it works, and how it is given. It also describes the evidence (clinical trials) to date, the possible side-effects, and the availability of Selinexor in the UK.

Cover image of 'Isatuximab'

Isatuximab (December 2019)

Myeloma UK

Isatuximab is a new drug that is being investigated for the treatment of myeloma. This factsheet describes briefly what it is, how it works, how it is given, the possible benefits over existing drugs, the possible side-effects, and its availability in the UK.

Sorry, no publications found.
Need to talk? Call us free*
0800 808 00 00 Monday to Friday, 9am-8pm